NEWS & EVENTS 
SPECIALTY CARE
I have pretty much all diabetes in my practice. If you’re seeing one of my patients, you better be putting one of these bad boys on! Because it’s a game changer in all this. And then a lot of folks come back and say, ‘Hey, now I want to do this.’ —Panelist and Family Nurse Practitioner
I'm talking to patients all the time, but all that I’m able to bill for is the placement, and then I have to attach that first 72 hours of data to my note in order to get paid for that. So as far as interpretation, we've been told that even though we're doing CGM interpretations, we're not going to get paid for it as pharmacists. —Panelist and Pharmacist
At our regional meetings earlier this year, members voiced a need to further operationalize workflows for CGMs in their primary care practices.
On September 1, 2022, the Michigan Collaborative for Type 2 Diabetes held a live webinar with a panel of members with expertise in implementing continuous glucose monitors (CGMs) in their primary care practices.
The panel discussed the following topics:
- Identifying patients who may be right for a CGM.
- Workflows associated with receiving CGM data from patients.
- Workflows associated with how CGM data is uploaded to the EMR/reviewed prior to, or during patient appointments.
- Roles in the office related to CGM prescribing (e.g. introducing a CGM to patients, providing education, uploading the data to the EMG, reviewing the data, etc.).
- Strategies for integrating CGM prescribing into a practice.
- Navigating insurance coverage for patients with Type 2 Diabetes.
Panelists include:
- Nadia Aneese, PharmD- Huron Valley Physicians Association
- Juan Reyes, PharmD- Olympia
- Jessica Prociv, PharmD- Bronson
- Susan Nason, Ambulatory Care Manager- Bronson
- Shirley Cardinal, RN Case Manager - Primary Care Partners
- Mary Wilson, FNP- Metro Health
Six game-changing takeaways from our panel of CGM implementation specialists:
1. Try placing CGM order through pharmacy benefit FIRST before trying Durable Medical Equipment (DME)—with the exception of Medicare patients.
Sending to a patient's local pharmacy or even a mail order or big box store pharmacy is often the quicker, cheaper, and more convenient option for patients and providers. This is especially true for patients with commercial insurance and some Medicare Advantage plans.
“For patients with high deductibles, going through pharmacy is immensely cheaper. If someone has a high deductible or a DME percentage payment, I always start with pharmacy because the difference for one patient was starting out at $240 vs $40 as a pharmacy benefit. If it doesn’t work, they’ll get back to me, and we try DME.” —Family Nurse Practitioner
2. DME Hacks: Getting CGMs through DME benefits can be a huge headache. Use Parachute Health, a DME ePrescribing tool, which works with some (but not all) DME suppliers. Get to know the DME representative for your practice. Not all DME suppliers are created equally.
"J & B will send you personalized order forms for your office if you ask them, it gives you that one touch with them (rather than a two step request then custom form request process)." —Ambulatory Care Manager
"I don't know why you still use them. I can't tell you the hours wasted and the interruption in care that occurs as a result of their inability to process or explain [the DME approval process], even though we do this every single day." —Family Nurse Practitioner
"We used to have to wait two months for approval, and I'd call weekly. As soon as I hit fax, [the DME rep] knows about it. My Freestyle Libre rep gave me her phone number and it's been a lifesaver." —Case Manager
3. Coverage Hack: Make the case for medical necessity whenever possible.
Panelists found success in written appeals for patients who have comorbidities that make finger stick impossible–vision impairments, Alzheimer's, dementia, Parkinson’s, hand neuropathy, even if the patient is not taking insulin.
4. Documentation shortcuts: Attach the CGM report document to the clinic note or add small sections directly into the note. This may expedite the process to assign a billing code.
5. EMR shortcut: Our panel makes use of order sets and dot phrases to standardize and speed up the ordering process.
Especially useful when key support personnel—like medical assistants and diabetes educators—are stretched thin.
6. Ongoing CGM use is great, but temporary use can also be beneficial for patients who cannot afford or who must pay out of pocket for the device.
If CGMs aren’t within a patient’s budget, even having a two week trial or wearing intermittently can provide valuable insights, encouragement for behavior change. Get to know your Abbott, Dexcom rep—a great way to get sample devices and to learn each manufacturer's preferred DME suppliers.
"There’s a lot more back and forth when it goes through DME. Abbott has a list of DME companies they work with. The more you do, the easier it becomes. I found this out last week: Dexcom for Medicare, they prefer the RX to go to Walgreens." —Pharmacist
What's Next
Heidi Diez, PharmD, pharmacist lead for MCT2D and her cohort of MCT2D pharmacists are working on a Parachute Tips Sheet for Providers, COMING SOON.
Panelists agreed on a much needed topic for a future learning community discussion: CGM billing, specifically how to pursue reimbursement for the team efforts to provide CGM interpretations in clinic, often led by clinical pharmacists. There is a need to share best practices on billing and learn from the wisdom of the collaborative.
Related CGM News and Events
MCT2D September 2025 Newsletter
Last updated: Thursday, September 25, 2025
PO Monthly Digest September 2025
Last updated: Wednesday, July 23, 2025
Value Based Reimbursement
- The new value-based reimbursement year for primary care physicians begins on 9/1/2025.
- Physicians approved for VBR will be visible in the portal on 9/2/2025 based on the lists that the PO admin leads/primary contacts reviewed in July.
Meetings
- PO calls this month are on Monday, September 8th at 11am and Wednesday, September 10th at 2pm.
- The September learning community event will take place on Friday, September 26th, and will be led by Rina Hisamatsu, RDN, and be focused on low carbohydrate diets. Register here.
- Registration for the fall regional meetings (taking place Wednesday, October 22nd and Thursday, November 13th) will open in September.
Tools
- MCT2D has created a patient focused handout on urine albumin creatinine ratio screening. The tool is available here
- We are also finalizing a provider-focused uACR tool and will be sharing it within the next couple of weeks. Upon release, you will have the opportunity to review the tool right away and provide feedback on its utility, earning physician-level learning community credit for your input.
- The MCT2D endocrinology leads have been developing a suite of tools for patients who are on insulin, and we hope to have these available to the collaborative before the end of the month. We will notify clinical champions via email once these are available.
Other
- MCT2D has partnered with Advanced Health Technology Solutions (AHTS) to help support the health information exchange. Ed Worthington from AHTS will be reaching out to each PO to set up a meeting to understand your current data submission process and ACRS attribution.
- The MCT2D smartphone application is now available! If you haven’t downloaded it, please click this link for more information.
- MCT2D is working on updates to the MCT2D Admin Portal to make it more streamlined and user friendly based on feedback from users. We hope to launch a new version this fall.
New Resources: Urine-to-Creatinine Ratio Test (uACR) - Guides for Clinicians and Patients
Last updated: Friday, September 12, 2025
MCT2D is excited to announce the release of two new handouts focused on the urine albumin-to-creatinine ratio (uACR) test, a key measure for detecting early kidney damage in people living with type 2 diabetes.
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.